Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Current Assets (2017 - 2025)

Historic Current Assets for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q2 2025 value amounting to $12.6 million.

  • CollPlant Biotechnologies' Current Assets fell 3791.98% to $12.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $12.6 million, marking a year-over-year decrease of 3791.98%. This contributed to the annual value of $13.2 million for FY2024, which is 5296.55% down from last year.
  • According to the latest figures from Q2 2025, CollPlant Biotechnologies' Current Assets is $12.6 million, which was down 3791.98% from $12.1 billion recorded in Q1 2025.
  • CollPlant Biotechnologies' Current Assets' 5-year high stood at $45087.0 billion during Q4 2021, with a 5-year trough of $12.6 million in Q2 2025.
  • Moreover, its 5-year median value for Current Assets was $45.3 million (2021), whereas its average is $2514.2 billion.
  • Per our database at Business Quant, CollPlant Biotechnologies' Current Assets skyrocketed by 79434450887.95% in 2021 and then crashed by 9992.98% in 2022.
  • Quarter analysis of 5 years shows CollPlant Biotechnologies' Current Assets stood at $45087.0 billion in 2021, then tumbled by 99.93% to $31.7 billion in 2022, then plummeted by 99.91% to $28.0 million in 2023, then tumbled by 52.97% to $13.2 million in 2024, then decreased by 4.22% to $12.6 million in 2025.
  • Its Current Assets was $12.6 million in Q2 2025, compared to $12.1 billion in Q1 2025 and $13.2 million in Q4 2024.